Each person’s Ulcerative Colitis (UC) journey is unique to them, highly unpredictable and can affect every aspect of their lives – so it is no surprise that holistic remission is gaining momentum in current practice as the ultimate goal of UC treatment and management. We are delighted to have had the opportunity to speak to Professor Vermeire on the topic of holistic remission and explore how it is transforming the management landscape for people with UC. She discussed how we can translate holistic remission into clinical practice successfully, the existing barriers to adopting such an approach, and how we raise the patient voice via shared decision-making, improved communication, and feedback to achieve better patient outcomes.
Listen to the podcast below!
About Professor Séverine Vermeire
Prof. Séverine Vermeire obtained her MD and PhD at KU Leuven. She trained at the National University of Asuncion, Paraguay, the Wellcome Trust Centre for Human Genetics, University of Oxford, UK, and the Montreal General Hospital, Canada. Since 2003, she has been a member of the Gastroenterology Department at University Hospitals Leuven and Professor of Medicine at KU Leuven. She became Head of the Department of Chronic Diseases and Metabolism (CHROMETA) at KU Leuven in 2016. Prof. Vermeire’s work has led to over 500 peer-reviewed articles and focusses on the role of the microbiome, genetic susceptibility in IBD and identifying predictive signatures of treatment response.
About Ginny Taliadouros
Ginny Taliadouros is a Global Medical Director for gastroenterology at Galapagos. She has a Masters in Cell and Molecular biology & Biomedical Sciences from Utrecht University, Netherlands. She has over 10 years of industry experience working across immunology, gastroenterology, and dermatology, where she held various roles within medical communications, scientific knowledge management and medical advisory at a global and regional level, including EMEA and emerging markets.